|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 8755 |
FusionGeneSummary for CTDSP2_B4GALNT1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CTDSP2_B4GALNT1 | Fusion gene ID: 8755 | Hgene | Tgene | Gene symbol | CTDSP2 | B4GALNT1 | Gene ID | 10106 | 2583 |
| Gene name | CTD small phosphatase 2 | beta-1,4-N-acetyl-galactosaminyltransferase 1 | |
| Synonyms | OS4|PSR2|SCP2 | GALGT|GALNACT|GalNAc-T|SPG26 | |
| Cytomap | 12q14.1 | 12q13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2NLI-interacting factor 2conserved gene amplified in osteosarcomanuclear LIM interactor-intera | beta-1,4 N-acetylgalactosaminyltransferase 1GD2 synthase, GM2 synthaseGM2/GD2 synthaseUDP-Gal:betaGlcNAc beta-1,4-N-acetylgalactosaminyltransferase transferase 1UDP-N-acetyl-alpha-D-galactosamine:(N-acetylneuraminyl)-galactosylglucosylceramide N-acety | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | O14595 | Q00973 | |
| Ensembl transtripts involved in fusion gene | ENST00000398073, ENST00000548823, ENST00000547701, | ENST00000341156, ENST00000418555, ENST00000449184, ENST00000550764, ENST00000552350, ENST00000550943, | |
| Fusion gene scores | * DoF score | 26 X 5 X 7=910 | 3 X 1 X 2=6 |
| # samples | 22 | 3 | |
| ** MAII score | log2(22/910*10)=-2.0483630215614 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/6*10)=2.32192809488736 | |
| Context | PubMed: CTDSP2 [Title/Abstract] AND B4GALNT1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CTDSP2 | GO:0006470 | protein dephosphorylation | 12721286 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | LGG | TCGA-DU-7013-01A | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000398073 | ENST00000341156 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000398073 | ENST00000418555 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000398073 | ENST00000449184 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000398073 | ENST00000550764 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000398073 | ENST00000552350 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000398073 | ENST00000550943 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000548823 | ENST00000341156 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000548823 | ENST00000418555 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000548823 | ENST00000449184 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000548823 | ENST00000550764 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000548823 | ENST00000552350 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| 5CDS-5UTR | ENST00000548823 | ENST00000550943 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| intron-5UTR | ENST00000547701 | ENST00000341156 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| intron-5UTR | ENST00000547701 | ENST00000418555 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| intron-5UTR | ENST00000547701 | ENST00000449184 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| intron-5UTR | ENST00000547701 | ENST00000550764 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| intron-5UTR | ENST00000547701 | ENST00000552350 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
| intron-5UTR | ENST00000547701 | ENST00000550943 | CTDSP2 | chr12 | 58240155 | - | B4GALNT1 | chr12 | 58025916 | - |
Top |
FusionProtFeatures for CTDSP2_B4GALNT1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CTDSP2 | B4GALNT1 |
| Preferentially catalyzes the dephosphorylation of 'Ser-5' within the tandem 7 residue repeats in the C-terminal domain(CTD) of the largest RNA polymerase II subunit POLR2A. Negativelyregulates RNA polymerase II transcription, possibly by controllingthe transition from initiation/capping to processive transcriptelongation. Recruited by REST to neuronal genes that contain RE-1elements, leading to neuronal gene silencing in non-neuronalcells. May contribute to the development of sarcomas.{ECO:0000269|PubMed:12721286, ECO:0000269|PubMed:15681389}. | Involved in the biosynthesis of gangliosides GM2, GD2and GA2. {ECO:0000269|PubMed:1601877}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CTDSP2_B4GALNT1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CTDSP2_B4GALNT1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CTDSP2 | POLR2A, SNAI1, CDCA3, CTDSP1, PLEKHH3, POM121, ZC3H3, ZMYM6, MAP7D1, INTS6, PRR14, ATP2B3, CWC22, SETD1A, UBTF, NEK4, ENDOD1, MAP7, SLC25A20, ATP12A, ANKRD13A, TBC1D4, BSG, DNAJA3, HAX1, P4HA1, RPS27L, TIMM50, TUBB6, ANKRD13D, NEK1, CSF1R, TYRO3, INSRR, PTK7, EPHA3, EPHA1, AKT1 | B4GALNT1 | B4GALNT1, ITM2B, TCTN2, TMED6, ST8SIA4, PCDH20, TRIM25 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CTDSP2_B4GALNT1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CTDSP2_B4GALNT1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | B4GALNT1 | C1836632 | SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE (disorder) | 1 | ORPHANET;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|